-653
Days Left
Lead Plaintiff Deadline: August 17, 2021
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
02
Feb 2021
10
Jun 2021
(i) the information submitted to the U.S. Food and Drug Administration (“FDA”) was insufficient to support an Emergency Use Authorization (“EUA”), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company’s financial statements, as well as Defendants’ statements about Ocugen’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
In order to be included in the lawsuit, you must have incurred a loss on shares of Ocugen purchased or acquired during the class period listed above.
If you suffered a loss in Ocugen during the relevant time frame, you have until August 17, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.